Rajiv Sharma, MD Radiology - Vascular & Interventional Radiology Medicare: Accepting Medicare Assignments Practice Location: 501 Kings Hwy E Ste 109, Fairfield, CT 06825 Phone: 203-330-0248 |
Robert D. Russo, M.D. Radiology - Diagnostic Radiology Medicare: Medicare Enrolled Practice Location: 75 Kings Highway Cutoff, Suite 1a, Fairfield, CT 06824 Phone: 203-815-1877 Fax: 203-538-5246 |
Gioia Jo Riccio, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 425 Post Rd, Fairfield, CT 06824 Phone: 203-683-4520 Fax: 203-926-1410 |
Daniel Jacob Machleder, MD Radiology - Vascular & Interventional Radiology Medicare: Accepting Medicare Assignments Practice Location: 1305 Post Rd, Suite 202, Fairfield, CT 06824 Phone: 203-426-2926 Fax: 203-292-6376 |
News Archive
The number of cases of kidney cancer has been rising over the last two decades, and new research from the University of Michigan Comprehensive Cancer Center shows that this increase is driven largely by the detection of small, presumably curable, kidney masses.
Stemedica Cell Technologies, Inc., ("Stemedica"), a world leader in stem cell research and manufacturing, announced the signing of an agreement today for its breakthrough stem cell and related technology. The Jordanian Stem Cell Company has signed a five year multi-million dollar agreement to purchase the technology from Stemedica's wholly-owned subsidiary, Stemedica International, S.A.
Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, today filed its second quarter Form 10-Q and reported its financial results. The report disclosed that the company's revenues slightly declined during the quarter but were more than offset by decreases in operating expenses and interest expense, resulting in a smaller net loss for the period.
Merck, known as MSD outside the United States and Canada, today provided the following statement after the conclusion of the Peripheral and Central Nervous System Drugs Advisory Committee meeting of the U.S. Food and Drug Administration about suvorexant, Merck's investigational medicine to treat insomnia.
Stereotypes about who will use online support groups are wrong, according to research at the University of Wisconsin-Madison. The researchers found that age, income and education did not predict participation, although minorities were not as active as other users.
› Verified 7 days ago